Apeloa Pharmaceutical Co. Ltd. Class A 000739

Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated MarketsSHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven pharmaceutical manufacturer, announced that it has been awarded the “2026 Global CDMO Company of the Year Award” by growth advisory fi